cytomegalovirus and herpes simplex virus infection in PV treated with rituximab and prednisolone. [3] Barnadas et al. also reported a case of paraneoplastic pemphigus associated with a CD20+ non-Hodgkin's lymphoma treated with rituximab, corticosteroids, and short courses of cyclosporine who developed sepsis due to Listeria monocytogenes and viral infections by human herpes virus 1 and 3 during the course of therapy. [4] Our patient was in a constant state of immunosuppression due to systemic glucocorticoids and mycophenolate mofetil, compounded by her rituximab infusions. On first infusion, the diagnosis of herpetic lesions the over the palm could have been missed if it was not suspected and confirmed by serology and response to acyclovir therapy. Autoinoculation and reactivation of HSV may explain the change in site of infection after the second infusion of rituximab therapy. Thus, immunosuppression resulting from rituximab therapy may trigger recurrent viral and other infections that may occur at a different site each time; this should be looked for in every suspected case. All pemphigus patients must be probed for a past history of herpes simplex infection; if positive they should be offered prophylactic acyclovir therapy during therapy, especially rituximab infusions, to prevent recurrence and possible disseminated infection.
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Sir, Acute generalized exanthematous pustulosis (AGEP) is a rare severe cutaneous reaction pattern related to drug intake in most cases. This condition was first described by Baker and Ryan in 1968. [1] The estimated incidence of AGEP is approximately 1-5 cases per million per year. [2] AGEP is mostly associated with antibiotics from the β-lactam and macrolide group and calcium channel blockers.
A 11-year-old boy admitted to the medical ward presented with the complaint of productive cough and high fever. On admission, he was diagnosed with chest infection and started with intravenous meropenem along with intravenous fluids and moist oxygen inhalation. Within 24 hours he had an Hypersensitivity reactions are known adverse effects of meropenem. In the first described case [3] of AGEP due to meropenem, the patient had septicemia and was on piperacillin, ceftazidime, and meropenem. The beta-lactam structure shared by the three antibiotics was thought be the cause of AGEP.
The adverse drug reaction scale by Naranjo et al. [4] (used to estimate the probability of a drug causing an adverse clinical event) estimated a 'probable' result since our patient's AGEP:
• followed a reasonable temporal sequence after the suspected drug, • followed a recognized response to the suspected drug, • was confirmed by withdrawal but not by exposure to the drug, and • could not be reasonably explained by the known characteristics of the patient's clinical state.
Literature search revealed only two similar case reports. The aim of this correspondence was not only to emphasize the recognition of this uncommon side effect of a commonly used drug, but also to stress the need to thoroughly investigate all cases of drug reaction.
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erythematous rash on the face and flexural areas accompanied by a burning sensation that spread to adjacent areas. Soon, hundreds of tiny pustules arose over the rash. There was no past history suggestive of psoriasis, past history suggestive of medical comorbidities or drug allergies.
Examination revealed an erythematous-edematous eruption over the face [ Figure 1a ], trunk and extremities [ Figure 1b ] studded with hundreds of small, discrete, and nonfollicular pustules [ Figure 1c ]. The patient had high fever (38-39°C). The hair, nails, and mucosal surfaces were normal. Systemic examination revealed no other abnormality. There was no significant lymphadenopathy. Considering the history, clinical features, and investigations including skin biopsy, and previous reports [3] of AGEP having been caused with meropenem, we diagnosed the patient to be having acute generalized exanthematous pustulosis due to meropenem.
Meropenem was discontinued; intravenous dexamethasone was administered in a dose of 3 mg, 6 hourly for five days. Emollient was applied on the rash, which subsided rapidly within two weeks with desquamation.
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Granuloma faciale
Sir, Granuloma faciale is a rare benign chronic inflammatory dermatosis of unknown etiology, which manifests as asymptomatic red-brown nodules or plaques usually confined to face. [1] Diagnosis is based on clinical features and histopathology. Recently, dermatoscopy is also useful as a diagnostic aid.
We describe a case of a 23-year-old woman who came with complaints of two asymptomatic red lesions over face since 3 months with no history of increase in size of lesions. On examination, there was evidence of two nontender erythematous papulo-nodules each on left temple and right cheek [ Figure 1a and b]. There was no evidence of enlarged nerves or loss of sensations or presence of any hypopigmented patch elsewhere over the body. There was no history of trauma or any medical or surgical illness. Family history was not significant. Dermoscopy could not be done due to unavailability. An excision biopsy was taken from the lesion over the left temple, which on histopathology showed presence of Grenz zone [ Figure 2a ] and dense mixed infiltration mainly consisting of eosinophils throughout the dermis with evidence of onion peel appearance of arterioles, suggestive of vasculitis [ Figure 2b and c]. The patient was given three sittings of intralesional steroids at an interval of three weeks with no improvement. Later, she was advised to apply topical tacrolimus ointment (0.1%) for one month leading to reduction in size of the lesion, which was finally excised. The patient was followed up for five months with no history of recurrence.
The term granuloma faciale was originally described by Wigley in 1945 as eosinophilic granuloma of the skin, further defined by Pinkus. [2] It mainly affects middle-aged white men between third and fifth decade. The etiology is usually unknown. Clinically, the lesions appear as asymptomatic well-circumscribed smooth erythematous papules, nodules, or plaques with follicular accentuation on sun-exposed sites. Majority of the lesions are confined to face with rare involvement of extra facial sites such as back, arms, chest, shoulders, and thighs.
The disease runs a chronic course without any systemic involvement. The main clinical differential diagnoses include leprosy, erythema elevatum diutinum, sarcoidosis, cutaneous lymphomas, pseudolymphoma, discoid lupus erythematosus, 
